+
Help Us Enhance Your NephU Experience

Help Us Enhance Your NephU Experience

User experience form

What are your goals for visiting NephU?(Required)
How would you like to hear from us?(Required)
Agree(Required)

Archives

Loading Events

Risk Factors For Rapid Disease Progression Of ADPKD

Risk Factors For Rapid Disease Progression Of ADPKD

In this presentation rapid disease progression of autosomal dominant polycystic kidney disease (ADPKD) will be defined. The risk factors that assist in determining if a patient is at risk of rapid disease progression will be discussed.

Location

Dallas Nephrology Associates Corporate Office

1505 LBJ Freeway, Suite 700
Dallas, TX 75234 United States
+ Google Map
214.358.2300 View Venue Website

Featuring

Frederic F Rahbari Oskoui

Frederic F Rahbari Oskoui, MD

Professor of Medicine, Nephrology, Emory University School of Medicine

Emory University School of Medicine*

Dr Frederic Rahbari is the director of Cystic Kidney Diseases Clinic at Emory University and has been a nephrologist practicing at Emory University Hospital in Atlanta, GA since 2006. Dr Rahbari attended medical school at Université de Bordeaux in France and completed a residency program at the same institution. After moving to the United States, Dr Rahbari did clinical and translational research on oxidative stress at New York Medical College and subsequently redid three years of residency training in internal medicine at St. Vincent Hospital -Columbia University College of Physicians and Surgeons. He has also completed a fellowship in nephrology at Emory University. Dr Rahbari has been a principal investigator in several PKD trials and is a member of the Scientific Advisory Committee of the Polycystic Kidney Disease Foundation.

Molly Jansen

Molly Jansen, PhD

Nephrology Senior Medical Science Liaison
Otsuka Pharmaceutical Development & Commercialization, Inc.*

Dr Molly Jansen is a Nephrology Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. covering South Texas. Molly earned her Doctor of Philosophy degree in Biomedical Science from Wake Forest School of Medicine located in Winston-Salem, NC. While in graduate school, Molly worked as a Business Development Intern at Wake Forest Innovations, fostering the collaborative innovation between industry and the faculty and staff of Wake Forest Baptist Medical Center. After graduate school, Molly did a brief Medical Writing Fellowship with Impact Pharmaceutical Services. Prior to joining Otsuka, Molly worked at Reata Pharmaceuticals, Inc. where she helped to oversee the conduct of clinical trials across a variety of therapeutic areas including nephrology, neurology, and pulmonary, which is where she developed her passion for rare disease.

*Dr Frederic F Rahbari Oskoui is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Molly Jansen is an employee of OPDC.

Registration

Join Today for Instant Access to all NephU Offerings.

Membership is free!

Join NephU today at no cost to register for this event and access to other premium content.

  • The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
  • Quickly learn more about the topics that interest you.
  • Access our library of on-demand kidney health resources
  • Gain key insights from industry experts & though leaders.